Treatment > Carboplatin / Vincristine


J Neurooncol. 2004 Mar-Apr;67(1-2):95-100


Abstract

Remission of a chiasmatic glioma in a non-NF1 patient after brief chemotherapy with vincristine and carboplatin: case report and literature review

Elpis Mantadakis, Maria Raissaki, Vassiliki Danilatou, Alexander Kambourakis, Eftichia Stiakaki and Maria Kalmanti

Department of Pediatric Hematology/Oncology [E.M., V.D., A.K., E.S., M.K.], Department of Radiology [M.R.], University Hospital of Heraklion, Heraklion, Crete, Greece.

We describe the case of an 8-year-old girl without neurofibromatosis, who presented with total loss of vision on the left eye, due to a chiasmatic mass with imaging characteristics of glioma, accompanied by a second asymptomatic mass in the middle cranial fossa, along the intracranial route of the right trigeminal nerve. 
The patient received a total of 10 weekly injections of vincristine and four injections of carboplatin every 3 weeks and achieved a very good partial response (97% volume reduction) after the nineth week of therapy with acceptable toxicity. 
Given the natural history of opticochiasmatic gliomas, we cannot rule out the possibility of a spontaneous regression. 
However, we believe the quick response accompanied by visual improvement was most likely due to chemotherapy. 
A trial of vincristine and carboplatin may be worthwhile in children with symptomatic chiasmatic gliomas, irrespective of their age.

PMID: 15072453 [PubMed]

Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15072453


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP